Start here if you're new
what it is
Syntec makes precision optics and photonics parts for defense, medical, and consumer customers.
how it gets paid
Last year Syntec Optics Hldgs made $28M in revenue. Defense optics and systems was the main engine at $14M, or 50% of sales.
what just happened
The quarter showed $21M in revenue, but Syntec still posted a loss.
At a glance
n/a balance sheet
-$0.07 fy2024 eps est
$29M fy2024 rev est
0.7% operating margin
~$246M market cap
What they do
Syntec makes precision optics and photonics parts for defense, medical, and consumer customers.
This is a specialized manufacturing shop, not a generic parts seller. Syntec has 159 employees and ships integrated optics for defense, medical, and consumer programs, which means your customer usually needs exact specs met, not a cheaper substitute. The recent $1.9 million LEO satellite optics order shows one line can scale from development to production, which is plain English for: once you are designed in, replacing you is painful.
How they make money
$28M
annual revenue
Defense optics and systems
$14M
+196%
Medical and consumer optics
$8M
flat
Optical services and assemblies
$6M
dn
The products that matter
military lens systems
Defense Optics
$4M order · 57% of a $7M quarter
this is the segment the market cares about right now. a single $4M defense order equaled 57% of one recent quarter's revenue, which tells you both the upside and the concentration risk.
contract-driven
augmented reality components
AR Optics
new OEM order · december 2025
the company said it received a new OEM order for U.S. soldier systems in december 2025. that matters because it points to repeat defense relevance, not just one lucky purchase order.
watch list
photonics components
Imaging Modules
$27.9M trailing revenue base
these products sit inside a business generating $27.9M in trailing revenue total. that's the quiet part: even the full company is still operating at micro-scale.
scale question
Key numbers
$28M
annual revenue
This is the whole sales base today, so every growth story has to start with a very small denominator.
-$0.16
trailing EPS
EPS → profit per share → so what: the company is still losing money on a trailing basis.
23.1%
gross margin
Gross margin → money left after making the product → so what: there is some product-level economics here, but not much room for mistakes below that line.
$3M
long-term debt
Debt → money owed long term → so what: the balance sheet is not the main problem, execution is.
Financial health
n/a
strength
- balance sheet grade n/a
- long-term debt $3M (1% of capital)
n/a — functional but not a standout on the balance sheet.
Total return vs. market
Return history isn't available for OPTX right now.
source: institutional data · return history unavailable
What just happened
missed estimates
The quarter showed $21M in revenue, but Syntec still posted a loss.
EDGAR shows latest-quarter revenue of $21 million, up 196% vs. prior year, while EPS was -$0.04. Translation: sales jumped, but the business did not convert that surge into profit.
$21M
revenue
-$0.04
eps
23.1%
gross margin
the number that mattered
Revenue grew 196% vs. prior year, and that is the whole case for paying attention because profits still are not there.
source: company earnings report, 2026
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
the top risk is defense contract concentration — this company is small enough that one customer win or loss can reshape an entire quarter.
high
defense contract concentration
A single $4M defense order represented 57% of a recent $7M quarter.
If that order slips, shrinks, or does not repeat, quarterly revenue can change dramatically.
high
no proven profitability
Net margin is -10.7% and return on equity is -27.3%.
Until earnings turn positive, every growth story still sits on a business that is destroying capital.
med
scale risk
Gross margin is 23.1%, but operating margin is only 0.7%.
That gap says the company needs more volume, better cost absorption, or both. Otherwise more revenue may not translate into much profit.
med
thin coverage and thin data
The xvary composite is unavailable, balance sheet grading is n/a, and institutional ownership data is still being compiled.
Less coverage means more room for mispricing. It also means you have fewer external guardrails if the thesis starts breaking.
The core problem is simple: a $29M revenue business with a -10.7% net margin cannot afford many misses when one $4M order already equals 57% of a quarter.
source: institutional data · regulatory filings · risk analysis
Pay attention to
key metric
net margin getting closer to zero
A move from -10.7% toward breakeven would tell you new orders are finally showing up in earnings, not just headlines.
risk
defense order follow-through
The march 9, 2026 defense award matters less as a press release than as recognized revenue and repeat demand.
calendar
management communication cadence
Events like the january 14, 2026 Optica summit appearance matter because thinly followed stocks often move on the quality of updates as much as the updates themselves.
trend
segment mix beyond defense
Medical and industrial plus consumer and AR are 43% of the mix today. You want that base to matter more if this is going to look like a business instead of a contract lottery.
Analyst rankings
wall street coverage
thin
There is not enough broad published coverage here to lean on ranking systems. in human-speak, you are mostly doing your own work.
price target visibility
limited
No usable target range is shown in the current feed, so the market is giving you volatility without much consensus framing.
signal quality
mixed
The business has real contract catalysts, but the dataset is too sparse to confuse activity with proof.
source: institutional data
Institutional activity
institutional ownership data for OPTX is being compiled.
source: institutional data
Price targets
3-5 year target range
n/a
n/a
$5
current price
n/a
target midpoint · n/a from current
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/moThe deep dive